Jca. Ter Steege et al., Oral spermine administration inhibits nitric oxide-mediated intestinal damage and levels of systemic inflammatory mediators in a mouse endotoxin model, SHOCK, 11(2), 1999, pp. 115-119
Enhanced intestinal nitric oxide production observed during sepsis is thoug
ht to play a central role in lipopolysaccharide-induced intestinal damage.
In contrast intestinal polyamines, both from endogenous and exogenous origi
n, are essential for the maintenance of mucosal integrity. Polyamines have
been shown to inhibit lipopolysaccharide-induced nitric oxide release in vi
tro and have been claimed to exert additional antiinflammatory actions. In
this study, the effect of the polyamine spermine on the release of the proi
nflammatory mediators nitric oxide and tumor necrosis factor-alpha by a mur
ine macrophage cell line was investigated. Furthermore, we investigated whe
ther oral spermine administration inhibits lipopolysaccharide-induced intes
tinal inducible nitric oxide synthase and nitrotyrosine expression and modu
lates the release of inflammatory mediators. Our results show that although
spermine inhibited lipopolysaccharide-induced nitric oxide release in a mu
rine macrophage cell line, no effect on tumor necrosis factor-alpha or rele
ase was observed. In addition, oral spermine administration inhibited intes
tinal inducible nitric oxide synthase and nitrotyrosine expression suggesti
ng a protective effect of spermine on lipopolysaccharide-induced intestinal
damage. In parallel a decrease in serum levels of the proinflammatory medi
ators nitrate, nitrite, and interferon-gamma and an increase in the antiinf
lammatory cytokine interleukin-10 was observed, although tumor necrosis fac
tor-alpha levels were unaffected. These results indicate that spermine inhi
bits lipopolysaccharide-induced nitric oxide release in vitro as well as in
vivo. Further, intraluminally derived polyamines modulate the systemic imm
une response. It is concluded that oral spermine administration might have
therapeutic perspectives for several disorders characterized by systemic in
flammation and intestinal damage.